| Period Ending | Period | Revenue ($m) | Pre-tax ($m) | EPS | Dividend |
|---|---|---|---|---|---|
| 31-Mar-26 | Q1 | 66.43 | 27.30 | 80.00¢ | 14.00¢ |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-21 | 121.33 | 38.00 | 225.90¢ | 5.2 | 0.5 | +11% | 50.00¢ | 4.2% |
| 31-Dec-22 | 142.08 | 39.64 | 219.90¢ | 6.3 | n/a | -3% | 70.00¢ | 5.0% |
| 31-Dec-23 | 146.31 | 7.97 | (43.60)¢ | n/a | n/a | n/a | 56.00¢ | 4.3% |
| 31-Dec-24 | 183.02 | 40.54 | 91.00¢ | 11.2 | n/a | n/a | 56.00¢ | 5.5% |
| 31-Dec-25 | 267.66 | 106.57 | 283.00¢ | 9.3 | 0.0 | +211% | 56.00¢ | 2.1% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-26 | 320.03 | 138.17 | 252.23p | 7.2 | 0.4 | +18% | 41.54p | 0.0% |
| 31-Dec-27 | 319.02 | 118.05 | 163.12p | 11.2 | n/a | -35% | 41.54p | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| 5 Yr High | 5 Yr Low | 5 Yr Avg | Curr / Avg | |
|---|---|---|---|---|
| Latest | 5.33 | 5.33 | 0.47 | 16.51 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
| Currency | UK Pounds |
| Share Price | 1,725.00p |
| Change Today | -100.00p |
| % Change | -5.48 % |
| 52 Week High | 2,900.00 |
| 52 Week Low | 1,085.00 |
| Volume | 2,741 |
| Shares Issued | 19.34m |
| Market Cap | £333.53m |
| RiskGrade | 174 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 0 |
| Buy | 2 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 2 |

| Latest | Previous | |
|---|---|---|
| 2nd Interim | 1st Interim | |
| Ex-Div | 22-May-26 | 02-Apr-26 |
| Paid | 05-Jun-26 | 17-Apr-26 |
| Amount | 14.00¢ | 14.00¢ |
| Time | Volume / Share Price |
| 16:13 | 1 @ 1,744.00p |
| 15:51 | 50 @ 1,715.00p |
| 15:50 | 60 @ 1,744.00p |
| 15:20 | 500 @ 1,740.00p |
| 15:03 | 110 @ 1,750.00p |
| CEO | John Mark Learmonth |
You are here: research